11:30 EDT Novartis (NVS) loses bid to block MSN generic of Entresto, Bloomberg says
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
- Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
- Sironax grants Novartis exclusive option to acquire BDM platform
- Novartis (NVS) Wins Landmark Approval for Baby Malaria Treatment
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!